192 related articles for article (PubMed ID: 2197908)
1. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.
Larsen RA; Leal MA; Chan LS
Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908
[TBL] [Abstract][Full Text] [Related]
2. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
[TBL] [Abstract][Full Text] [Related]
3. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
[TBL] [Abstract][Full Text] [Related]
4. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies.
Shapiro AE; Tenforde MW; Chiller TM; Ford N; Rajasingham R
HIV Med; 2023 Apr; 24(4):507-512. PubMed ID: 36123803
[TBL] [Abstract][Full Text] [Related]
5. Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
Boulware DR; Atukunda M; Kagimu E; Musubire AK; Akampurira A; Tugume L; Ssebambulidde K; Kasibante J; Nsangi L; Mugabi T; Gakuru J; Kimuda S; Kasozi D; Namombwe S; Turyasingura I; Rutakingirwa MK; Mpoza E; Kigozi E; Muzoora C; Ellis J; Skipper CP; Matkovits T; Williamson PR; Williams DA; Fieberg A; Hullsiek KH; Abassi M; Dai B; Meya DB
Clin Infect Dis; 2023 Dec; 77(12):1659-1667. PubMed ID: 37606364
[TBL] [Abstract][Full Text] [Related]
6. Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
Lalloo UG; Komarow L; Aberg JA; Clifford DB; Hogg E; McKhann A; Bukuru A; Lagat D; Pillay S; Mave V; Supparatpinyo K; Samaneka W; Langat D; Ticona E; Badal-Faesen S; Larsen RA;
PLoS One; 2023; 18(2):e0281580. PubMed ID: 36780493
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in managing HIV-associated cryptococcal meningitis.
Boyer-Chammard T; Temfack E; Alanio A; Jarvis JN; Harrison TS; Lortholary O
F1000Res; 2019; 8():. PubMed ID: 31275560
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Pastick KA; Nalintya E; Tugume L; Ssebambulidde K; Stephens N; Evans EE; Ndyetukira JF; Nuwagira E; Skipper C; Muzoora C; Meya DB; Rhein J; Boulware DR; Rajasingham R
Med Mycol; 2020 Apr; 58(3):282-292. PubMed ID: 31689712
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment.
Zhao H; Lu Y; Li S; Qin J; Xu M; Ye H; Yang Z; Rao J; Chen G; Su F; Hu Z; Xu L
Mycoses; 2024 Jan; 67(1):e13674. PubMed ID: 37986630
[TBL] [Abstract][Full Text] [Related]
10. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS
AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517
[TBL] [Abstract][Full Text] [Related]
11. Once-Weekly Liposomal Amphotericin B Use for Maintenance and Consolidation Phase Treatment of Cryptococcal Meningitis in Patients With AIDS.
Belinschi V; Iheagwara C; Muhanna A
Cureus; 2024 Mar; 16(3):e55824. PubMed ID: 38590504
[TBL] [Abstract][Full Text] [Related]
12. AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.
Molefi M; Chofle AA; Molloy SF; Kalluvya S; Changalucha JM; Cainelli F; Leeme T; Lekwape N; Goldberg DW; Haverkamp M; Bisson GP; Perfect JR; Letang E; Fenner L; Meintjes G; Burton R; Makadzange T; Ndhlovu CE; Hope W; Harrison TS; Jarvis JN
Trials; 2015 Jun; 16():276. PubMed ID: 26081985
[TBL] [Abstract][Full Text] [Related]
13. How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?
Harrison TS; Lawrence DS; Mwandumba HC; Boulware DR; Hosseinipour MC; Lortholary O; Meintjes G; Mosepele M; Jarvis JN
Clin Infect Dis; 2023 Mar; 76(5):944-949. PubMed ID: 36166405
[TBL] [Abstract][Full Text] [Related]
14. Major role for amphotericin B-flucytosine combination in severe cryptococcosis.
Dromer F; Bernede-Bauduin C; Guillemot D; Lortholary O;
PLoS One; 2008 Aug; 3(8):e2870. PubMed ID: 18682846
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational study.
Mashau RC; Meiring ST; Quan VC; Nel J; Greene GS; Garcia A; Menezes C; Reddy DL; Venter M; Stacey S; Madua M; Boretti L; Harrison TS; Meintjes G; Shroufi A; Trivino-Duran L; Black J; Govender NP;
Lancet Infect Dis; 2022 Sep; 22(9):1365-1373. PubMed ID: 35750065
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of induction therapy for human immunodeficiency virus-associated cryptococcal meningitis: a network meta-analysis.
Campbell JI; Kanters S; Bennett JE; Thorlund K; Tsai AC; Mills EJ; Siedner MJ
Open Forum Infect Dis; 2015 Jan; 2(1):ofv010. PubMed ID: 26034761
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.
O'Connor L; Livermore J; Sharp AD; Goodwin J; Gregson L; Howard SJ; Felton TW; Schwartz JA; Neely MN; Harrison TS; Perfect JR; Hope WW
J Infect Dis; 2013 Jul; 208(2):351-61. PubMed ID: 23599314
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of cryptococcal meningitis in HIV-infected adults.
McHale TC; Boulware DR; Kasibante J; Ssebambulidde K; Skipper CP; Abassi M
Clin Microbiol Rev; 2023 Dec; 36(4):e0015622. PubMed ID: 38014977
[TBL] [Abstract][Full Text] [Related]
19. Rapidly enlarging pulmonary mass due to immune reconstitution inflammatory syndrome (IRIS) in an immunocompetent host with pulmonary
Tucker M; Sheikh AM; Villanueva MS
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351746
[TBL] [Abstract][Full Text] [Related]
20. Disseminated
Fraser B; Munawar M; Halani S; Sabur N
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37993145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
